Abstract

Alterations in acute myeloid leukaemia bone marrow stromal cell exosome content coincide with gains in tyrosine kinase inhibitor resistance.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
CSF1R Is Associated with Poor Overall Survival in AML and Mediates Supportive Interactions Between AML and Stromal Cells in the AML Microenvironment
Mark D Minden ... Michael D Jain
Blood | VOL. 128
Mark D Minden, et. al.Mark D Minden ... Michael D Jain
02 Dec 2016
The CXCR4 Antagonist BL-8040 Efficiently Induces Apoptosis and Inhibits The Survival Of AML Cells
Orly Eizenberg ... Sigal Tavor
Blood | VOL. 122
Orly Eizenberg, et. al.Orly Eizenberg ... Sigal Tavor
15 Nov 2013
Characterization of Mesenchymal Stromal Cells (MSCs) Derived From Acute Myeloid Leukemia (AML) Bone Marrow
Soumit K Basu ... Pamela S Becker
Blood | VOL. 118
Soumit K Basu, et. al.Soumit K Basu ... Pamela S Becker
18 Nov 2011
Bone Marrow Stroma Protects FLT3 Acute Myeloid Leukemia (AML) through CYP3A4-Mediated Drug Metabolization of FLT3 Tyrosine Kinase Inhibitors (TKIs)
Yu-Ting Chang ... Gabriel Ghiaur
Blood | VOL. 130
Yu-Ting Chang, et. al.Yu-Ting Chang ... Gabriel Ghiaur
25 Jun 2021
View more papers

More From: British journal of haematology

Paper Title
Journal
Date
Author
Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T-cell therapy in Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Tamer Othman ... Ibrahim Aldoss
British journal of haematology | VOL. -
Tamer Othman, et. al.Tamer Othman ... Ibrahim Aldoss
29 May 2024
Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I-BFM Study Group.
Herbert Pichler ... Adriana Balduzzi
British journal of haematology | VOL. -
Herbert Pichler, et. al.Herbert Pichler ... Adriana Balduzzi
27 May 2024
Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDP.
Douglas A Stewart ... Michael Crump
British journal of haematology | VOL. -
Douglas A Stewart, et. al.Douglas A Stewart ... Michael Crump
27 May 2024
RUNX1::ETO and CBFβ::MYH11 converge on aberrant activation of BCAT1 to confer a therapeutic vulnerability in core-binding factor-acute myeloid leukaemia.
Siyang Wang ... Kankan Wang
British journal of haematology | VOL. -
Siyang Wang, et. al.Siyang Wang ... Kankan Wang
27 May 2024
View more papers